Myriad Genetics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Hi, everyone, welcome to the 2021 JPMorgan Healthcare Conference. My name is Casey Woodring and I'm a member of the life science tools and diagnostics equity research team here at JPMorgan. Today, it's my pleasure to introduce the management team from Myriad Genetics. As a reminder, if you would like to ask a question, please feel free to submit via the presentation web page. And with that, let me turn it over to Paul.
Great. Thank you, Casey. Thank the whole JPMorgan team, Tycho and the rest of the team, for allowing us the opportunity to present here today. And let me send a shout-out to all of my teammates at Myriad Genetics for their incredible efforts over the last few months of continuing to manage through this pandemic and how hard everyone is working to be responsive to our patients' needs.
We are excited today to give everyone an update of our transformation plan. And the progress that we're
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |